Kumthekar, P., Grimm, S. A., Aleman, R. T., Chamberlain, M. C., Schiff, D., Wen, P. Y., Iwamoto, F. M., Gursel, D. B., Reardon, D. A., Purow, B., Kocherginski, M., Helenowski, I., & Raizer, J. J. (2022). A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma. Neuro-Oncology Advances, 4(1). https://doi.org/10.1093/noajnl/vdac123